• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Antithrombin-III (SERPINC1)

ACP01785

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01785 Target NameSERPINC1
Target SynonymsSerpin C1FormLiquid or Lyophilized powder
Expression SystemMammalian cellExpression Range1-464aa(R294H)
Mol Weight54.7 kDaProtein LengthFull length
PurityGreater than 85% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP01008
Background Information
  • Uniprot Id

    P01008

  • Target Species

    Human

  • Target Name

    SERPINC1

  • Target Full Name

    Antithrombin-III

  • Target Function

    Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade. AT-III inhibits thrombin, matriptase-3/TMPRSS7, as well as factors IXa, Xa and XIa. Its inhibitory activity is greatly enhanced in the presence of heparin.

  • Target Involvement

    Antithrombin III deficiency (AT3D)

  • Target Subcellular Location

    Secreted, extracellular space.

  • Target Protein Families

    Serpin family

  • Target Tissue Specificity

    Found in plasma.

  • Target Research Area

    Cardiovascular

  • Target Synonyms

    Serpin C1

  • Target Background

    The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. A reduction in the serum level of this protein is associated with severe cases of Coronavirus Disease 19 (COVID-19).

Inquire Recombinant Human Antithrombin-III (SERPINC1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification